Human biomonitoring (HBM) constitutes a crucial tool that contributes to the chemicals risk assessment and consequently to the Regulatory Toxicology. Allowing the determination of the internal exposure to certain chemicals at individual level, HBM data provide evidence that can further support the prioritization of actions and measures for policy decisions. Additionally, it contributes to evaluate the effectiveness of regulatory measures already established aiming to prevent/reduce exposure to hazardous substances, and to promote more comprehensive health impact assessments. Past (e.g. COPHES and DEMOCOPHES) and ongoing research projects (e.g. HBM4EU) have been able to demonstrate the usefulness of HBM in different regulatory frameworks and how the science-to-policy interface can be strengthned through the inclusion of HBM data.
It is expected that the work being developed in the ongoing research projects will contribute to the overarching goal of ensuring that EU chemical policies minimize their adverse effects on human health. HBM can have an important role for the refinement of the existent policies and also to identify the needs of new regulatory actions.
To accomplish this and to increase the science-to-policy interface, it is of particular importance to establish a platform that could serve the needed role of gathering and disseminating the most relevant findings under this scope, and be available as a repository for the policy and regulatory actors.
In this Research Topic, we are welcoming contributions related to the topic as outlined above. Specifically, the following areas of research are of interest:
- Research work describing the added value of HBM for policy action (e.g. new regulation and/or improve the one already in place).
- Case studies where HBM was used to modify the existent regulatory framework;
- Examples of initiatives where HBM data were successfully used under the scope of the science-to-policy interface;
- Studies providing scientific evidence using HBM that would be used under the scope of risk assessment, and consequently, supporting regulatory toxicology.
--
Different Article Types can be submitted to the Research Topic including Original Research, Review, Mini-Review, Brief Research Report, Perspective articles, among others. You can find detailed information
here.
Human biomonitoring (HBM) constitutes a crucial tool that contributes to the chemicals risk assessment and consequently to the Regulatory Toxicology. Allowing the determination of the internal exposure to certain chemicals at individual level, HBM data provide evidence that can further support the prioritization of actions and measures for policy decisions. Additionally, it contributes to evaluate the effectiveness of regulatory measures already established aiming to prevent/reduce exposure to hazardous substances, and to promote more comprehensive health impact assessments. Past (e.g. COPHES and DEMOCOPHES) and ongoing research projects (e.g. HBM4EU) have been able to demonstrate the usefulness of HBM in different regulatory frameworks and how the science-to-policy interface can be strengthned through the inclusion of HBM data.
It is expected that the work being developed in the ongoing research projects will contribute to the overarching goal of ensuring that EU chemical policies minimize their adverse effects on human health. HBM can have an important role for the refinement of the existent policies and also to identify the needs of new regulatory actions.
To accomplish this and to increase the science-to-policy interface, it is of particular importance to establish a platform that could serve the needed role of gathering and disseminating the most relevant findings under this scope, and be available as a repository for the policy and regulatory actors.
In this Research Topic, we are welcoming contributions related to the topic as outlined above. Specifically, the following areas of research are of interest:
- Research work describing the added value of HBM for policy action (e.g. new regulation and/or improve the one already in place).
- Case studies where HBM was used to modify the existent regulatory framework;
- Examples of initiatives where HBM data were successfully used under the scope of the science-to-policy interface;
- Studies providing scientific evidence using HBM that would be used under the scope of risk assessment, and consequently, supporting regulatory toxicology.
--
Different Article Types can be submitted to the Research Topic including Original Research, Review, Mini-Review, Brief Research Report, Perspective articles, among others. You can find detailed information
here.
